Literature DB >> 6693133

Study on C3-like factor in the serum of a C3-deficient subject.

H Kitamura, H Nishimukai, Y Sano, K Nagaki.   

Abstract

Analysis of the serum of an individual having a deficiency of C3 (C3D) revealed that despite the fact that the C3 could not be detected immunochemically, a small amount of C3 haemolytic activity and total complement activity was indeed found to be present. The present study was performed to analyse the C3-like factor, responsible for this C3 activity in C3D serum. It was found that the C3-like factor was not neutralized by anti-C3 but was neutralized by anti-C5. The electrophoretic mobility of the C3-like factor corresponded to that of purified C5. Thus, C3-like factor was shown to have the antigenicity and electrophoretic mobility of C5. This factor was found in the sera of three other C3D subjects and even in pooled normal human serum (NHS). These findings suggest that, in cases of C3D, C5 compensates for the genetic lack of C3 and serves a protective function and that sensitized erythrocytes (EA) may be lysed by complement components without participation of C3.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693133      PMCID: PMC1454427     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Fifth component of human complement: purification from plasma and polypeptide chain structure.

Authors:  B F Tack; S C Morris; J W Prahl
Journal:  Biochemistry       Date:  1979-04-17       Impact factor: 3.162

2.  Immunofixation electrophoresis: a technique for the study of protein polymorphism.

Authors:  C A Alper; A M Johnson
Journal:  Vox Sang       Date:  1969-11       Impact factor: 2.144

3.  Isolation and properties of a glycine-rich beta-glycoprotein of human serum.

Authors:  T Boenisch; C A Alper
Journal:  Biochim Biophys Acta       Date:  1970-12-22

4.  Complement fixing abilities of IgA myeloma proteins and their fragments: the activation of complement through the classical pathway.

Authors:  K Iida; T Fujita; S Inai; M Sasaki; T Kato
Journal:  Immunochemistry       Date:  1976-09

5.  Genetically determined deficiency of the third component of complement in the dog: in vitro studies on the complement system and complement-mediated serum activities.

Authors:  J A Winkelstein; J P Johnson; A J Swift; F Ferry; R Yolken; L C Cork
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

7.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

8.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

9.  Complement deficiency and nephritis. A report of a family.

Authors:  B A Pussell; E Bourke; M Nayef; S Morris; D K Peters
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

10.  A low molecular weight inhibitor of the alternative complement pathway. I. Its isolation from human urine and the reaction mechanism.

Authors:  K Nagaki; M Matsumoto; H Kitamura
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

View more
  9 in total

1.  Apparently non-expressed alleles of factor B (BF) code for hypomorphic proteins.

Authors:  I Siemens; M Brenden; G Mauff; M Abbal; E Du Toit; J Bertrams; G Geserick
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.

Authors:  H Kitamura; M Matsumoto; K Nagaki
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

3.  Molecular basis of hereditary C3 deficiency.

Authors:  M Botto; K Y Fong; A K So; A Rudge; M J Walport
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Homozygous hereditary C3 deficiency due to a partial gene deletion.

Authors:  M Botto; K Y Fong; A K So; R Barlow; R Routier; B J Morley; M J Walport
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.

Authors:  H Kitamura; M Tsuboi; K Nagaki
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

6.  Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.

Authors:  H Kitamura; M Tsuboi
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

7.  C3-independent immune haemolysis: mechanism of membrane attack complex formation.

Authors:  H Kitamura; M Tsuboi; K Nagaki
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

8.  Complement Deficiencies Result in Surrogate Pathways of Complement Activation in Novel Polygenic Lupus-like Models of Kidney Injury.

Authors:  Sladjana Skopelja-Gardner; Lucrezia Colonna; Payton Hermanson; Xizhang Sun; Lena Tanaka; Joyce Tai; Yenly Nguyen; Jessica M Snyder; Charles E Alpers; Kelly L Hudkins; David J Salant; YuFeng Peng; Keith B Elkon
Journal:  J Immunol       Date:  2020-04-01       Impact factor: 5.422

9.  The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.

Authors:  Yousuke Higuchi; Junya Shimizu; Michiyo Hatanaka; Etsuko Kitano; Hajime Kitamura; Hidetoshi Takada; Masataka Ishimura; Toshiro Hara; Osamu Ohara; Kenji Asagoe; Toshihide Kubo
Journal:  Pediatr Rheumatol Online J       Date:  2013-10-28       Impact factor: 3.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.